华纳药厂：12款药品拟中选国家组织集采药品协议期满品种接续采购

Core Viewpoint - Warner Pharmaceuticals (688799) has announced its participation in the national organized procurement for drugs whose agreements have expired, with 12 products expected to be selected for the continuation of procurement [2] Group 1: Financial Impact - The expected sales revenue from the selected products for 2024 is 176 million yuan, accounting for 12.47% of the company's total revenue for that year [2] - For the period of January to September 2025, the anticipated sales revenue is 192 million yuan, representing 17.69% of the company's revenue for that period [2]